COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
The newly emergent novel coronavirus disease 2019 (COVID-19) outbreak, which is caused by SARS-CoV-2 virus, has posed a serious threat to global public health and caused worldwide social and economic breakdown. Angiotensin-converting enzyme 2 (ACE2) is expressed in human vascular endothelium, respir...
Main Authors: | Razie Amraei, Nader Rahimi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1652 |
Similar Items
-
C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors
by: Nader Rahimi
Published: (2020-12-01) -
Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies
by: Hai Deng, et al.
Published: (2021-05-01) -
Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions
by: Yujiro Matsuishi, et al.
Published: (2021-03-01) -
ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01) -
Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells
by: Francesca Benedetti, et al.
Published: (2021-10-01)